Source - SMW
Cancer-detection company Oncimmune said it had signed a new distribution agreement for Turkey.

The deal brought the total number of agreements in Europe and the Asia Pacific region to 12, with total minimum sales commitments of £25.6m.

"We continue to deliver on our plan to create value from our core autoantibody platform and the board is increasingly confident that the company is well placed to execute that plan and deliver value in the medium and long term," Oncimmune said.


At 9:44am: (LON:ONC) Oncimmune Holdings Plc share price was +1.5p at 131.5p